Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MotherToBaby to Share Pregnancy, Breastfeeding Resources on World Psoriasis Day

Resources Include Study Examining Psoriatic Disease during Pregnancy


News provided by

MotherToBaby

Oct 29, 2021, 04:50 ET

Share this article

Share toX

Share this article

Share toX


LA JOLLA, Calif., Oct. 29, 2021 /PRNewswire-PRWeb/ -- MotherToBaby Pregnancy Studies, a collaboration between the Organization of Teratology Information Specialists (OTIS) and UC San Diego School of Medicine, announced their plans to participate in World Psoriasis Day activities on Friday October 29, 2021. Over 125 million people are living with psoriasis, many of whom may be individuals who are currently pregnant or breastfeeding or who are contemplating future parenthood. The goal is to share MotherToBaby's wealth of resources on psoriatic disease during pregnancy and lactation, including increasing awareness of their observational research studies that are looking at the effects of psoriatic disease and their treatments during pregnancy.

On October 29, 2021, MotherToBaby's will host an Instagram Takeover with Senior Information Specialist, Robert Felix, to discuss what is known about psoriatic disease in pregnancy and lactation and to spotlight MotherToBaby's available resources and study opportunities. Those who are interested in joining the conversation can follow @MotherToBabyOTIS on Instagram all day to participate in the #WPD2021 awareness campaign.

The goal of our study is to gather information from pregnant people with psoriatic disease so we can better understand whether or not medications they are already taking may affect their pregnancy or their developing baby.

Post this

Evaluating the Safety of Psoriatic Disease Medications in Pregnancy

MotherToBaby Pregnancy Studies provides real-world evidence on the safety of medications when used during pregnancy. Pregnant people and individuals considering pregnancy who are living with psoriasis or psoriatic arthritis are encouraged to talk to their healthcare provider about enrolling in these important observational research studies. "For many medications used to treat psoriasis and psoriatic arthritis, we don't currently have adequate information to say that the treatment is safe to take if you are pregnant," said Christina Chambers, PhD, MPH, lead investigator of MotherToBaby Pregnancy Studies and professor of pediatrics at UC San Diego. "The goal of our study is to gather information from pregnant people with psoriatic disease so we can better understand whether or not medications they are already taking may affect their pregnancy or their developing baby. Collecting these data is critical to helping healthcare providers and families gain insight into whether a given psoriatic disease treatment can safely be continued during pregnancy—information that could have a major impact on the well-being of the pregnant parent." Chambers added that participants in their studies are not asked to take or change any medications, and the study can be completed from the comfort of the participant's home.

Pregnant people living with psoriasis or psoriatic arthritis are asked to consider enrolling into MotherToBaby Pregnancy Studies to give parents-to-be better answers about how psoriatic disease and its management can affect a pregnancy and a developing baby.

Healthcare providers are also encouraged to refer their patients to see if they qualify. To learn more about MotherToBaby Pregnancy Studies, call (877) 311-8972, email [email protected] or visit MotherToBaby.org.

Share Our Resources to Improve the Health Literacy of Pregnant People with Psoriatic Disease

MotherToBaby Pregnancy Studies Website
Psoriasis Resource Page
Psoriatic Arthritis Resource Page
Psoriasis and Psoriatic Arthritis Fact Sheet
Pregnancy Studies FAQ Flyer
Patient Referral Form for Counseling/and Study Info
Patient Education & Provider Resources on Dermatology
Self-Referral Sign Up Form

About MotherToBaby

MotherToBaby is the nation's leading authority and most trusted source of evidence-based information on the safety of medications, health conditions and other exposures during pregnancy and while breastfeeding. In addition to research studies, they provide free evidence-based information on exposures to both the public and healthcare providers throughout the US and Canada. MotherToBaby is a suggested resource by many federal agencies including the Centers for Disease Control and Prevention (CDC).

Media Contact

Schedule an interview with Robert Felix or Dr. Chambers about the importance of pregnancy studies on psoriatic disease this World Psoriasis Day by contacting Nicole Chavez at 619.368.3259 or [email protected]. Stress, anxiety and depression are common for people living with psoriatic disease. Our experts our also available to discuss mental health exposures and other conditions like COVID-19 infection in pregnancy and while breastfeeding.

Media Contact

Nicole Chavez, MotherToBaby, 6193683259, [email protected]

Twitter, LinkedIn, Facebook

SOURCE MotherToBaby

Related Links

https://mothertobaby.org/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.